Entasis Therapeutics Holdings Inc (ETTX)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

35 GATEHOUSE DRIVE WALTHAM, MA 02451

Entasis is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel antibacterial products to treat serious infections caused by multidrug-resistant Gram-negative bacteria. Entasis' pathogen-targeted design platform has produced a pipeline of product candidates, including sulbactam-durlobactam (targeting Acinetobacter baumannii infections), zoliflodacin (targeting Neisseria gonorrhoeae infections), ETX0282CPDP (targeting Enterobacteriaceae infections) and ETX0462 (targeting Pseudomonas infections).

Data as of 2021-07-25 17:37:29 -0400
Market Cap93.276 Million Shares Outstanding37.31 Million Avg 30-day Volume149.137 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-0.06 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.83375 52-week High/Low3.74 / 1.58 Next Earnings Date2021-08-04 Price to Cash FLow (P/CF) -9.3101
Data provided by IEX Cloud
View SEC Filings from ETTX instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 1 0.0% 0 (0.0%) 0 (0.0%)
Funds Holding: 26 26 0.0% 6 (0.35%) 8 (0.46%) -25.0%
13F shares: 4.366 Million 4.519 Million -3.4% 1.04 Million 810.792 Thousand 28.32%
% Ownership 11.7014 12.7395 -8.15% 2.7885 2.2855 22.01%
New Positions: 4 11 -63.64% 5
Increased Positions 11 6 83.33% 5 1 400.0%
Closed Positions 4 16 -75.0% 2 7 -71.43%
Reduced Positions 5 3 66.67% 1
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ETTX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ETTX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

12.5 Million total shares from 2 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

TRIOLA ANNA DIAZ CHIEF COMMERCIAL OFFICER

  • Officer
0 2021-07-19 2

INNOVIVA, INC.

INNOVIVA STRATEGIC OPPORTUNITIES LLC

  • 10% Owner
57,345,794 2021-06-11 3

HASTINGS DAVID C

  • Director
22,000 2021-04-01 1

BEHANNA HEATHER

  • Director
22,000 2021-04-01 1

MEEK DAVID D.

  • Director
22,000 2021-04-01 1

MAYER HOWARD

  • Director
22,000 2021-04-01 1

GUTCH MICHAEL CFO & CBO

  • Officer
25,000 2021-01-15 1

MUELLER JOHN PATRICK CHIEF DEVELOPMENT OFFICER

  • Officer
25,000 2021-01-15 1

PERROS MANOUSSOS PRESIDENT & CEO

  • Officer
  • Director
79,750 2021-01-15 1

TOMMASI RUBEN CHIEF SCIENTIFIC OFFICER

  • Officer
47,024 2021-01-15 1

KEILEY ELIZABETH M GENERAL COUNSEL

  • Officer
25,000 2021-01-15 1

ALTARAC DAVID CHIEF MEDICAL OFFICER

  • Officer
25,000 2021-01-15 1

RONSHEIM MATTHEW SEE REMARKS

  • Officer
25,000 2021-01-15 2

INNOVIVA, INC.

  • 10% Owner
18,672,897 2020-09-01 3

KIMBLE ERIC WILSON CHIEF COMMERCIAL OFFICER

  • Officer
0 2020-01-23 0

FRAZIER LIFE SCIENCES VIII, L.P.

TOPPER JAMES N

FHM LIFE SCIENCES VIII, L.P.

FHM LIFE SCIENCES VIII, L.L.C.

HERON PATRICK J

  • 10% Owner
No longer subject to file 2020-01-09 0

GALAKATOS NICHOLAS

  • Director
0 2019-06-19 0

NORDEN GREGORY

  • Director
0 2019-06-19 0

PRESTON HEATHER

  • Director
0 2019-06-19 0

ISAACS ROBIN CHIEF MEDICAL OFFICER

  • Officer
0 2019-01-18 0

TOPPER JAMES N

  • Director
  • 10% Owner
0 2019-01-18 0

BLACKSTONE HOLDINGS II L.P.

BLACKSTONE CLARUS III L.L.C.

BLACKSTONE HOLDINGS I/II GP INC

BLACKSTONE GROUP L.P.

BLACKSTONE GROUP MANAGEMENT L.L.C.

SCHWARZMAN STEPHEN A

  • 10% Owner
1,623,405 2019-01-04 0

ASTRAZENECA PLC

ASTRAZENECA AB

  • 10% Owner
2,164,855 2018-09-28 0

FRAZIER LIFE SCIENCES VIII, L.P.

FHM LIFE SCIENCES VIII, L.L.C.

HERON PATRICK J

FHM LIFE SCIENCES VIII, L.P.

  • 10% Owner
1,349,953 2018-09-28 0

CLARUS LIFESCIENCES III, L.P.

CLARUS VENTURES III GP, L.P.

CLARUS VENTURES III, LLC

SIMON NICHOLAS

LIPTAK ROBERT

HENNER DENNIS

REQUADT SCOTT

WHEELER KURT

  • 10% Owner
2,308,575 2018-09-28 0

PIVOTAL BIOVENTURE PARTNERS FUND I, L.P.

PIVOTAL BIOVENTURE PARTNERS FUND I G.P., L.P.

PIVOTAL BIOVENTURE PARTNERS FUND I U.G.P., LTD

  • 10% Owner
1,539,445 2018-09-28 0

SOFINNOVA VENTURE PARTNERS IX, L.P.

SOFINNOVA MANAGEMENT IX, L.L.C.

HEALY JAMES

MEHRA ANAND

POWELL MICHAEL

  • 10% Owner
1,180,178 2018-09-28 0

TPG GROUP HOLDINGS (SBS) ADVISORS, INC.

BONDERMAN DAVID

COULTER JAMES G

  • 10% Owner
  • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
1,020,748 2018-09-28 0

NOVO HOLDINGS A/S

  • 10% Owner
2,181,843 2018-09-28 0

STAPLES ANDREW J.

  • Director
0 2018-09-25 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

TRIOLA ANNA DIAZ - Officer CHIEF COMMERCIAL OFFICER

2021-07-20 16:06:16 -0400 2021-07-19 A 100,000 a 100,000 direct

INNOVIVA, INC. - > 10% Owner see footnote

INNOVIVA STRATEGIC OPPORTUNITIES LLC - > 10% Owner see footnote

2021-06-11 17:39:43 -0400 2021-06-11 P 6,268,975 $2.00 a 10,000,000 indirect -9.5395 -8.8816 -23.8487 0.0 1 -23.8487 31

INNOVIVA, INC. - > 10% Owner see footnote

INNOVIVA STRATEGIC OPPORTUNITIES LLC - > 10% Owner see footnote

2021-06-11 17:39:43 -0400 2021-06-11 P 6,268,975 $2.00 a 10,000,000 indirect

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ENTASIS THERAPEUTICS HOLDING ETTX 2021-07-28 17:15:03 UTC -6.9605 7.0405 700000
ENTASIS THERAPEUTICS HOLDING ETTX 2021-07-28 16:45:03 UTC -6.2818 6.3618 700000
ENTASIS THERAPEUTICS HOLDING ETTX 2021-07-28 16:15:02 UTC -6.2818 6.3618 700000
ENTASIS THERAPEUTICS HOLDING ETTX 2021-07-28 15:45:03 UTC -6.2818 6.3618 700000
ENTASIS THERAPEUTICS HOLDING ETTX 2021-07-28 15:15:03 UTC -6.2818 6.3618 700000
ENTASIS THERAPEUTICS HOLDING ETTX 2021-07-28 14:45:02 UTC -5.153 5.233 700000
ENTASIS THERAPEUTICS HOLDING ETTX 2021-07-28 14:15:03 UTC -5.153 5.233 700000
ENTASIS THERAPEUTICS HOLDING ETTX 2021-07-28 13:45:02 UTC -5.153 5.233 650000
ENTASIS THERAPEUTICS HOLDING ETTX 2021-07-28 13:15:03 UTC -5.153 5.233 650000
ENTASIS THERAPEUTICS HOLDING ETTX 2021-07-28 12:45:03 UTC -5.153 5.233 650000
ENTASIS THERAPEUTICS HOLDING ETTX 2021-07-27 22:15:03 UTC -5.153 5.233 700000
ENTASIS THERAPEUTICS HOLDING ETTX 2021-07-27 21:45:03 UTC -5.153 5.233 700000
ENTASIS THERAPEUTICS HOLDING ETTX 2021-07-27 21:15:03 UTC -5.153 5.233 700000
ENTASIS THERAPEUTICS HOLDING ETTX 2021-07-27 20:45:03 UTC -5.153 5.233 700000
ENTASIS THERAPEUTICS HOLDING ETTX 2021-07-27 20:15:03 UTC -5.153 5.233 700000
ENTASIS THERAPEUTICS HOLDING ETTX 2021-07-27 19:45:02 UTC -5.153 5.233 700000
ENTASIS THERAPEUTICS HOLDING ETTX 2021-07-27 19:15:02 UTC -5.153 5.233 700000
ENTASIS THERAPEUTICS HOLDING ETTX 2021-07-27 18:45:03 UTC -6.2818 6.3618 700000
ENTASIS THERAPEUTICS HOLDING ETTX 2021-07-27 18:15:02 UTC -6.2818 6.3618 700000
ENTASIS THERAPEUTICS HOLDING ETTX 2021-07-27 17:45:03 UTC -6.2818 6.3618 700000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments